Supn stock
WebAsset Growth. 0.22%. Trailing 12-Months. The Supernus Pharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating ... WebView live Supernus Pharmaceuticals, Inc chart to track its stock's price action. Find market predictions, SUPN financials and market news.
Supn stock
Did you know?
WebSUPN: Lowering target price to $37.00 SUPERNUS PHARMACEUTICALS INC has an Investment Rating of HOLD; a target price of $37.000000; an Industry Subrating of … Web6 apr 2024 · One share of SUPN stock can currently be purchased for approximately $37.09. How much money does Supernus Pharmaceuticals make? Supernus …
WebView the latest SUPN stock quote and chart on MSN Money. ... SUPN) Expected to Post Quarterly Sales of $166.35 Million ETF Daily News 5/29/2024. Supernus Pharmaceuticals ... WebSee Supernus Pharmaceuticals, Inc. (SUPN) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.
WebSupernus Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ... Stock Price Target SUPN. High $ 45.00: Median $ 44.00: Low $ 38.00: Average $ 42.75 ... Web11 apr 2024 · A high-level overview of Supernus Pharmaceuticals, Inc. (SUPN) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and …
WebWith Supernus Pharmaceuticals stock trading at $35.77 per share, the total value of Supernus Pharmaceuticals stock (market capitalization) is $1.95B. Supernus Pharmaceuticals stock was originally listed at a price of $5.37 in May 1, 2012. If you had invested in Supernus Pharmaceuticals stock at $5.37, your return over the last 10 years …
WebStock analysis for Supernus Pharmaceuticals Inc (SUPN:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. phila water contaminationWebVertex Pharmaceuticals stock (NASDAQ: VRTX) has seen a 33% rise this year, significantly outperforming the broader S&P500 index, down 23%. By Trefis Team Contributor Sep … phila water problemWebSUPN Stock Summary. With a price/earnings ratio of 31.29, SUPERNUS PHARMACEUTICALS INC P/E ratio is greater than that of about 78.78% of stocks in our set with positive earnings. Price to trailing twelve month operating cash flow for SUPN is currently 16.26, higher than 67.51% of US stocks with positive operating cash flow. phila water newsWebSupernus to Participate in Two Upcoming Investor Conferences. ROCKVILLE, Md., March 08, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today that the … phila water iceWeb12 apr 2024 · Get undefined (SUPN.P) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments phila water one time paymentWebThe 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price … phila web masters.wordpress.comWeb10 apr 2024 · View the latest Supernus Pharmaceuticals Inc. (SUPN) stock price, news, historical charts, analyst ratings and financial information from WSJ. phila water spill